Influence of the Differentiated Therapeutic Approach on Bioelectrical Activity of the Brain in Patients with Parkinson’s Disease and Dyscirculatory Encephalopathy of Atherosclerotic and Hypertensive Origin with Parkinsonian Syndrome

T.V. Chernii


The objective of our study was to evaluate the changes in clinical and neurological, neurophysiological, neurotransmitter predictors of bioelectrical activity of the brain in patients with Parkinson’s disease (PD) and dyscirculatory encephalopathy of atherosclerotic and hypertensive origin with parkinsonian syndrome before the start of drug treatment and during the causal treatment. More significant cholinergic system failure in the central nervous system (CNS) was detected in the group of patients with PD. Electroencephalographic parameters that characterize the acti-vity of dopaminergic system were reduced in both groups. Features of neurotransmitter deficiency predetermined the prescription of pathogenetic therapy. The use of selective dopamine receptor agonists and glutamate receptor blockers (original amantadine sulfate) is indicated to the patients from both groups. Inclusion in the treatment of Parkinson’s disease (group 1) and dyscirculatory encephalopathy with parkinsonian syndrome (group 2) of complexes of drugs: selective dopamine receptor agonist + original amantadine sulfate — increases the proportion of favorable res-ponses of the CNS.


Parkinson’s disease; dyscirculatory encephalopathy of atherosclerotic and hypertensive origin; parkinsonian syndrome; quantitative electroencephalography; bioelectrical activity of the brain; neurotransmitter systems; types of central nervous system


Болезнь Паркинсона и расстройства движений: Руководство для врачей / Под ред. С.Н. Иллариошкина, Н.Н. Яхно. — М., 2008. — 405 с.

Голубев В.Л., Левин Я.И., Вейн А.М. Болезнь Паркинсона и синдром паркинсонизма. — М.: МЕДпресс, 1999.

Шарова Е.В. Современные возможности ЭЭГ в анализе функциональных нарушений при тяжелых повреждениях головного мозга // Нейронауки: теоретичні та клінічні аспекти. — 2009. — Т. 5, № 1–2. — С. 49-58.

Лях Ю.Е., Гурьянов В.Г., Хоменко В.Н., Панченко О.А. Основы компьютерной биостатистики: анализ информации в биологии, медицине и фармации статистическим пакетом MedStаt. — Донецк: Папакица Е.К., 2006. — 214 с.

Острова Т.В., Черній В.І., Шевченко А.І. Алгоритм діагностики реактивності ЦНС методами штучного інтелекту. — Донецьк: Наука і освіта, 2004. — 180 с.

Островая Т.В. Исследование реактивности ЦНС в ответ на фармакологическое воздействие (Тиоцетам) / Т.В. Островая, В.И. Черний, И.А. Андронова // Междунар. неврол. журн. — 2007. — № 2 (12). — С. 53-62.

Babiloni C., De Pandis M., Vecchio F. et al. Cortical sources of resting state electroencephalographic rhythms in Parkinson’s disease related dementia and Alzheimer's disease // Clin. Neurophysiol. — 2011. — 122 (12). — 2355-2364.

Desplats P., Lee H.J. Inclusion formation and neuronal cell death through neuron-to-neuron transmission of alpha-synuclein // Proc. Nalt. Acad. Sci USA. — 2009. — Vol. 106. — P. 13010-13015.

Parnetti L. Choline alphoscerate in cognitive decline and in acute cerebrovascular disease: an analysis of published clinical data // Mechanisms of Ageing and Development. — 2001. — 122. — P. 2041-2055.

Morita A., Kamei S., Mizutani T. Relationship between slowing of the EEG and cognitive impairment in Parkinson disease // J. Clin. Neurophysiol. — 2011. — 28 (4). — 384-387.

Serizawa K., Kamei S., Morita A. et al. Comparison of quantitative EEGs between Parkinson disease and age-adjusted normal controls // J. Clin. Neurophysiol. — 2008. — 25 (6). — 361-366.

Tanaka H., Koenig T., Pascual-Marqui R. Event-related potential and EEG measures in Parkinson's disease without and with dementia // Dement Geriatr. Cogn. Disord. — 2000. — 11. — 39-45.


Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 International License.


© Publishing House Zaslavsky, 1997-2020


   Seo анализ сайта